Academic Bibliography

Show Sort by

Your filters: cql: parent exact "HEPATOLOGY"

Mark
- journalArticle
- A1
Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice

Sarah Raevens (UGent), Anja Geerts (UGent), Annelies Paridaens, Sander Lefere (UGent), Xavier Verhelst (UGent), Anne Hoorens (UGent), Jo Van Dorpe (UGent), Tania Maes (UGent), Ken Bracke (UGent), Christophe Casteleyn (UGent), et al.

(2018) HEPATOLOGY.
Mark
- journalArticle
- A1
Milder disease stage in patients with primary biliary cholangitis over a 44-year period : a changing natural history

Fiorella Murillo Perez, Jorn C Goet, Willem J Lammers, Aliya Gulamhusein, Henk R van Buuren, Cyriel Y Ponsioen, Marco Carbone, Andrew Mason, Christophe Corpechot, Pietro Invernizzi, et al.

(2018) HEPATOLOGY.
Mark
- misc
Refractory subacute steatohepatitis after biliopancreatic diversion

Sander Lefere (UGent), Anne Hoorens (UGent), Sarah Raevens (UGent), Roberto Troisi (UGent), Xavier Verhelst (UGent), Hans Van Vlierberghe (UGent) and Anja Geerts (UGent)

(2017) HEPATOLOGY. 66(1). p.289-291
Mark
- conference
- C3
Time-dependent factors associated with diminished transplant-free survival in patients with primary biliary cholangitis and an optimal response to ursodeoxycholic acid after one year of treatment

Willem J Lammers, Jorn C Goet, Marlyn J Mayo, Ann-Arosa Floreani, Pietro Invernizzi, Maren H Harms, Christophe Corpechot, Keith D Lindor, Cyriel Y Ponsioen, Harry L Janssen, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.157A-158A
Mark
- conference
- C3
Time trends in major hepatic complications in primary biliary cholangitis : incidence and transplant-free survival

Maren H Harms, Willem J Lammers, Douglas Thorburn, Christophe Corpechot, Pietro Invernizzi, Harry L Janssen, Pier Maria Battezzati, Frederik Nevens, Keith D Lindor, Annarosa Floreani, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.40A-40A
Mark
- conference
- C3
Recurrence of primary biliary cholangitis after liver transplantation affects graft survival : a multi-center study from the Global PBC study group

Aldo J Montano-Loza, Bettina E Hansen, Davide Roccarina, Douglas Thorburn, Palak J Trivedi, Gideon Hirschfield, Christophe Corpechot, Raoul Poupon, Jerome Dumortier, Alexie Bosch, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.163A-164A
Mark
- conference
- C3
Bilirubin is predictive of transplant-free survival even within the normal range in primary biliary cholangitis patients

Carla F. Murillo Perez, Aliya Gulamhusein, Henk R. van Buuren, Willem J. Lammers, Jorn C. Goet, Cyriel Y. Ponsioen, Marco Carbone, Andrew Mason, Christophe Corpechot, Marlyn J. Mayo, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.41A-42A
Mark
- conference
- C3
Moving from early to moderate or advanced biochemical disease stage during follow-up is associated with an increasing risk of clinical events in primary biliary cholangitis patients

Nikolaos K Gatselis, Jorn C Goet, Kalliopi Zachou, Willem J Lammers, Harry L Janssen, Gideon Hirschfield, Christophe Corpechot, Keith D Lindor, Pietro Invernizzi, Marlyn J Mayo, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.169A-170A
Mark
- conference
- C3
Association between ursodeoxycholic acid therapy and prolonged transplant-free survival among patients with primary biliary cholangitis a number needed to treat analysis

Maren H Harms, Annarosa Floreani, Douglas Thorburn, George N Dalekos, Harry L Janssen, Christophe Corpechot, Pietro Invernizzi, Marlyn J Mayo, Pier Maria Battezzati, Henk R van Buuren, et al.

(2016) HEPATOLOGY. 64(suppl. 1). p.188A-188A
Mark
- conference
- C3
Placental growth factor inhibition alleviates hepatopulmonary syndrome in mice

Sarah Raevens (UGent), Annelies Paridaens, Sander Lefere (UGent), Bart Jonckx, Xavier Verhelst (UGent), Hans Van Vlierberghe (UGent), Christophe Van Steenkiste (UGent), Anja Geerts (UGent), Lindsey Devisscher (UGent) and Isabelle Colle (UGent)

(2016) HEPATOLOGY. 64(suppl. 1). p.82A-82A

Academic Bibliography

Biblio has been updated

Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice

Milder disease stage in patients with primary biliary cholangitis over a 44-year period : a changing natural history

Refractory subacute steatohepatitis after biliopancreatic diversion

Time-dependent factors associated with diminished transplant-free survival in patients with primary biliary cholangitis and an optimal response to ursodeoxycholic acid after one year of treatment

Time trends in major hepatic complications in primary biliary cholangitis : incidence and transplant-free survival

Recurrence of primary biliary cholangitis after liver transplantation affects graft survival : a multi-center study from the Global PBC study group

Bilirubin is predictive of transplant-free survival even within the normal range in primary biliary cholangitis patients

Moving from early to moderate or advanced biochemical disease stage during follow-up is associated with an increasing risk of clinical events in primary biliary cholangitis patients

Association between ursodeoxycholic acid therapy and prolonged transplant-free survival among patients with primary biliary cholangitis a number needed to treat analysis

Placental growth factor inhibition alleviates hepatopulmonary syndrome in mice

Contents

Support

Contact